Welcome back to another episode of MedCity FemFwd, a podcast dedicated to exploring the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Cathleen Brown, medical

Anthropic is rolling out Claude Science, an AI workbench for pharma researchers. The buzzy AI startup says this new product goes beyond assisting scientists to actually doing their work.  “Claude

It’s been a busy few months for Servier, which followed its $2.5 billion acquisition of cancer biotech Day One Biopharmaceuticals with a $1.5 billion agreement to buy the neuromuscular business

For decades, cameras in hospital corridors were a valuable tool for capturing forensic evidence, though they were not yet the proactive security asset we see today. That model is changing

Ipsen has become an active dealmaker as it pursues growth in oncology, and its latest move is the $450 million acquisition of Kartos Therapeutics, a clinical-stage biotech whose lead program

Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several

AI tools are quickly creating new opportunities for innovation in the medical world, which could provide much-needed support to specialities like radiology where clinicians suffer from systemic burnout and workforce

The flux around CMS Star Ratings continues. Lawsuits from health insurers over Medicare Advantage Star Ratings have increased in recent years, though with varying results. Some plans like SCAN and

A Viridian Therapeutics drug for thyroid eye disease now has FDA approval, making it just the second therapy for this inflammatory disorder and one offering key competitive advantages over the

Healthcare has spent the better part of a decade building data lakes. The original problem was straightforward and worth solving: clinical data lived in silos, providers could not see the